FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine. Described are biomaterials prepared by mixing an autocross-linked derivative of hyaluronic acid with hyaluronic acid derivative cross-linked with 1,4-butandiol diglycidyl ether (BDDE) in a weight ratio from 10:90 to 90:10, as new fillers.
EFFECT: biomaterials make is possible to promote the immediate regeneration/restoration of dermal/skin tissue, which has lost its initial tightness.
7 cl, 2 dwg, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VISCOELASTIC GELS AS NOVEL FILLERS | 2014 |
|
RU2692800C2 |
| SPLIT-RESISTANT LOW MOLECULAR CROSS-LINKED HYALURONATE | 2012 |
|
RU2613887C2 |
| STABILIZED HYALURONIC ACID | 2019 |
|
RU2805502C2 |
| BIOMATERIALS CONSISTING OF SULPHATED HYALURONIC ACID AND HELLANE APPLIED FOR PREVENTION OF COMMISSURES IN SPINE | 2005 |
|
RU2383336C2 |
| DERMAL FILLER COMPOSITION FOR SMALL WRINKLES TREATING | 2012 |
|
RU2626513C2 |
| GEL OF HYALURONIC ACID FOR INTRACUTANEOUS INJECTION | 2007 |
|
RU2448740C2 |
| CROSS-LINKED HYALURONIC ACIDS AND THEIR APPLICATION IN MEDICINE | 1999 |
|
RU2230752C2 |
| DERMAL FILLERS COMPOSITIONS, INCLUDING ANTIOXIDANTS | 2012 |
|
RU2624239C2 |
| BIOLOGICAL MATERIAL APPLICABLE FOR THERAPY OF OSTEOARTHROSIS, LIGAMENTOUS INJURY AND FOR TREATING JOINT PATHOLOGIES | 2010 |
|
RU2529803C2 |
| DERMAL FILLER COMPOSITIONS, INCLUDING ANTIOXIDANTS | 2012 |
|
RU2740454C2 |
